Opus Genetics, Inc. (IRD)

NASDAQ: IRD · Real-Time Price · USD

3.980

-0.080 (-1.97%)

At close: Nov 13, 2026, 4:00 PM EST

4.095

+0.115 (2.89%)

After-hours: Nov 13, 2026, 5:59 PM EST

Opus Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	88.97	45.09	30.32	50.5	42.63	24.53
Short-Term Investments	-	-	0	0.02	0.05	0.22
Cash & Short-Term Investments	88.97	45.09	30.32	50.52	42.68	24.75
Cash Growth	188.74%	48.70%	-39.97%	18.35%	72.44%	50.94%
Accounts Receivable	1.63	3.17	5.77	2.33	4.85	-
Receivables	3.32	3.17	5.77	2.33	4.85	-
Prepaid Expenses	1.96	1.79	0.52	1.1	1.37	1.24
Other Current Assets	0.61	-	-	-	0.08	0.07
Total Current Assets	94.86	50.04	36.61	53.95	48.99	26.07
Property, Plant & Equipment	0.34	0.2	0.25	-	0.01	0.01
Total Assets	95.3	50.24	36.86	53.95	48.99	26.08

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.73	3.29	3.15	2.15	1.07	1.58
Accrued Expenses	6.11	4.47	7.54	1.82	1.37	1.73
Short-Term Debt	-	-	-	-	-	0.54
Current Income Taxes Payable	-	-	-	-	0.32	-
Other Current Liabilities	-	0.02	0.61	0.07	-	-
Total Current Liabilities	9.83	7.78	11.3	4.04	2.75	3.86
Long-Term Debt	35.88	1.13	-	-	-	-
Other Long-Term Liabilities	11.15	25.99	-	-	-	-
Total Liabilities	56.86	34.9	11.3	4.04	2.75	3.86

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	346.03	203.93	145.72	131.37	117.72	111.59
Retained Earnings	-308.72	-188.59	-139	-81.47	-71.48	-89.37
Total Common Equity	38.43	15.35	6.72	49.91	46.24	22.22
Shareholders' Equity	38.43	15.35	25.57	49.91	46.24	22.22
Total Liabilities & Equity	95.3	50.24	36.86	53.95	48.99	26.08

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	35.88	1.13	-	-	-	0.54
Net Cash (Debt)	53.09	43.96	30.32	50.52	42.68	24.22
Net Cash Growth	78.48%	44.98%	-39.97%	18.35%	76.27%	47.66%
Net Cash Per Share	0.58	0.71	1.14	2.34	2.07	1.63
Filing Date Shares Outstanding	96.65	71.15	45.48	24.81	20.95	18.99
Total Common Shares Outstanding	95.8	69.89	31.57	23.98	20.86	18.85
Working Capital	85.02	42.26	25.32	49.91	46.23	22.21
Book Value Per Share	0.40	0.22	0.21	2.08	2.22	1.18
Tangible Book Value	38.43	15.35	6.72	49.91	46.24	22.22
Tangible Book Value Per Share	0.40	0.22	0.21	2.08	2.22	1.18
Machinery	-	-	-	-	0.03	0.03

SEC Filings: 10-K · 10-Q